ESMO Preceptorship on Lymphoma 2018: Lugano
![ESMO Preceptorship on Lymphoma Lugano 2018](/var/esmo/storage/images/media/images/conferences/2018/preceptorships-2018/esmo-preceptorship-on-lymphoma-lugano-2018/2388524-1-eng-GB/ESMO-Preceptorship-on-Lymphoma-Lugano-2018.jpg)
- Start date
- 16 Nov 2018
- End date
- 17 Nov 2018
- Location
- Lugano, Switzerland
Learning objectives
- To highlight the pathological bases of the most recent lymphoma classification
- To understand the role of PET in staging, re-staging and follow-up
- To review the treatment strategy for the most common lymphoma types
- To dissect the peculiarities of lymphomas arising in particular extranodal sites
- To illustrate special and innovative treatment strategies
- To discuss clinical cases between faculty and participants
Accreditation
The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Martin Dreyling, Germany
- Marco Ladetto, Italy